Rankings
▼
Calendar
VSTM Q1 2019 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$1M
67.1% margin
Operating Income
-$35M
-2074.8% margin
Net Income
-$38M
-2280.2% margin
EPS (Diluted)
$-6.19
QoQ Revenue Growth
+38.1%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$39M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$243M
Total Liabilities
$155M
Stockholders' Equity
$88M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$1M
$0
—
Operating Income
-$35M
-$21M
-67.0%
Net Income
-$38M
-$21M
-81.0%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$282,000
65%
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$104,000
24%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$43,000
10%
Product Revenue And Allowances Returns
$4,000
1%
← FY 2019
All Quarters
Q2 2019 →